Related Experiment Video

Updated: Nov 1, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.2K

Obstacles impeding the development of nanocarriers for anticancer drugs

Lingshan Liu1, Hongjing Dou1

  • 1The State Key Laboratory of Metal Matrix Composites, School of Materials Science & Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR China.

Nanomedicine (London, England)
|June 18, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
endocytosismononuclear phagocytic systemnanomedicineprotein coronatumor penetration

More Related Videos

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.8K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.2K

Related Experiment Videos

Last Updated: Nov 1, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.2K
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.8K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K

Articles linked to this work by shared authors, journal, and citation graph.

Decoding mechanoregulation in immunological synapses using biomimetic artificial cells.

Nature methods·2026

Nanoparticle Internalization into Protocells through Dynamic Membrane Remodeling Guided by Electrostatic Repulsion.

ACS nano·2026

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

Oncogene·2026

Dynamically Crosslinked Carbon Dot/Alginate Hydrogels for On-Demand Osteomyelitis Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026

D-π-A sensitized carbon dots as long-lived type-I/Ⅱ photosensitizers for NIR-excited hypoxia-regulated photodynamic therapy.

Nature communications·2026

Programmable Coacervate-Membrane Interactions Direct Internal and Collective Organization in Membranized Protocells.

Angewandte Chemie (International ed. in English)·2026

Cationic lipid-based targeted nanocarriers for respiratory diseases in children: prospects and challenges.

Nanomedicine (London, England)·2026

LPR-1-Mediated targeted intranasal delivery of lentinan-loaded polymeric nanocarriers for GBM therapy via modulation of apoptotic signalling.

Nanomedicine (London, England)·2026

Intradermal immunoengineering with mRNA.

Nanomedicine (London, England)·2026

Considerations for nanoscale drug-delivery systems for the cornea.

Nanomedicine (London, England)·2026

Advances in the development and application of nanofibrous systems for intranasal drug delivery.

Nanomedicine (London, England)·2026

Bacterial extracellular vesicles: mechanisms, engineering strategies, and therapeutic potential for inflammatory bowel disease.

Nanomedicine (London, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us